ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,016Medicare Part D Prescriptions Filled, Including Refills

Rank: 324 out of 1692

$666K Total Retail Price of All Prescriptions

Rank: 122 out of 1692

388 Patients Receiving at Least One Drug in Part D
86%Patients 65 Years and Older
31% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Virginia
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

4% of this provider’s 388 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

0% of this provider’s 6,949 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

33% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$83 was the average price of a prescription from this provider, compared to $55 among peers.

Prescriptions per Patient

21 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Virginia
SIMVASTATIN 417 364 1 1
AMLODIPINE BESYLATE 369 334 2 3
DIOVAN 261 247 3 42
LISINOPRIL 249 235 4 2
CRESTOR 219 155 5 26
LEVOTHYROXINE SODIUM 213 192 6 4
OMEPRAZOLE 206 189 7 5
METFORMIN HCL 201 157 8 8
ATORVASTATIN CALCIUM 195 178 9 11
FUROSEMIDE 191 188 10 7
METOPROLOL SUCCINATE 163 142 11 18
LOSARTAN POTASSIUM 159 154 12 17
DIOVAN HCT 134 102 13 73
PRAVASTATIN SODIUM 122 107 14 12
BYSTOLIC 99 85 15 129
CARVEDILOL 94 93 16 24
EXFORGE 92 92 17 229
TAMSULOSIN HCL 89 83 18 31
ZOLPIDEM TARTRATE 86 53 19 23
SERTRALINE HCL 84 80 20 22
ATENOLOL 84 52 20 15
AZITHROMYCIN 83 69 22 34
WARFARIN SODIUM 81 80 23 14
METFORMIN HCL ER 80 61 24 49
VERAPAMIL ER 78 74 25 90
NAMENDA 77 77 26 50
HYDROCHLOROTHIAZIDE 76 76 27 9
CIPROFLOXACIN HCL 73 67 28 65
SPIRIVA 66 64 29 44
METOPROLOL TARTRATE 65 53 30 10
TRAMADOL HCL 64 52 31 16
AMLODIPINE BESYLATE-BENAZEPRIL 64 49 31 67
ALLOPURINOL 61 61 33 30
POTASSIUM CHLORIDE 60 60 34 20
ADVAIR DISKUS 57 57 35 45
LISINOPRIL-HYDROCHLOROTHIAZIDE 54 50 36 19
PREDNISONE 54 47 36 35
PROAIR HFA 53 47 38 40
GLIPIZIDE 53 39 38 47
HYDROCODONE-ACETAMINOPHEN 53 42 S3 38 6
LANTUS 52 52 41 57
LOSARTAN-HYDROCHLOROTHIAZIDE 51 51 42 38
FLUOXETINE HCL 50 35 43 52
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.